Y-mAbs Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. YMAB has around 3.3M shares in the U.S. ETF market. The largest ETF holder of YMAB is the SPDR S&P Biotech ETF (XBI), with approximately 1.22M shares. Investors may also find of interest that the ETF with the largest allocation to YMAB stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 2.27%. On average, U.S. ETFs allocate 0.16% of YMAB to their portfolios.

Additionally, YMAB is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with YMAB as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.